These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36315414)

  • 21. Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.
    Compston JE
    Eur J Endocrinol; 2023 Mar; 188(3):R46-R55. PubMed ID: 36880157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-induced osteoporosis: pathogenesis and management.
    Lukert BP; Raisz LG
    Ann Intern Med; 1990 Mar; 112(5):352-64. PubMed ID: 2407167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.
    Hardy RS; Zhou H; Seibel MJ; Cooper MS
    Endocr Rev; 2018 Oct; 39(5):519-548. PubMed ID: 29905835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of growth hormone in glucocorticoid-induced osteoporosis.
    Lombardi G; Colarusso S; Di Somma C; Guerra E; Tauchmanova L; Colao A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):38-42. PubMed ID: 18791350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid-induced osteoporosis: an update.
    Compston J
    Endocrine; 2018 Jul; 61(1):7-16. PubMed ID: 29691807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glucocorticoid-induced osteoporosis].
    Foltyn W; Kos-Kudła B; Marek B; Kajdaniuk D; Głogowska-Szelag J; Siemińska L; Strzelczyk J; Borowska M
    Endokrynol Pol; 2007; 58(2):170-5. PubMed ID: 17578833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
    Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
    J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glucocorticoids on bone density.
    Rehman Q; Lane NE
    Med Pediatr Oncol; 2003 Sep; 41(3):212-6. PubMed ID: 12868121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects.
    Mauras N
    Horm Res; 2001; 56 Suppl 1():13-8. PubMed ID: 11786679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid osteoporosis.
    Sambrook PN
    Curr Pharm Des; 2002; 8(21):1877-83. PubMed ID: 12171526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
    Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
    Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid osteoporosis.
    Reid IR; Veale AG; France JT
    J Asthma; 1994; 31(1):7-18. PubMed ID: 8175628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
    Canalis E; Mazziotti G; Giustina A; Bilezikian JP
    Osteoporos Int; 2007 Oct; 18(10):1319-28. PubMed ID: 17566815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
    Giustina A; Bussi AR; Jacobello C; Wehrenberg WB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):122-9. PubMed ID: 7829600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of impaired growth: effect of steroids on bone and cartilage.
    Olney RC
    Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma.
    Wisniewski AF; Lewis SA; Green DJ; Maslanka W; Burrell H; Tattersfield AE
    Thorax; 1997 Oct; 52(10):853-60. PubMed ID: 9404371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.
    Butler CC; Van Der Voort JH
    Cochrane Database Syst Rev; 2002; (4):CD001935. PubMed ID: 12519563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucocorticoid induced osteoporosis].
    Gutiérrez-Polo R
    An Sist Sanit Navar; 2003; 26 Suppl 3():63-80. PubMed ID: 14716359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.